MBBP Client Valeritas Files IPO 02/17/2015Posted by Morse, Barnes-Brown Pendleton in Client News.
Tags: Diabetes, financing, insulin, IPO, medical devices, SEC, VLRX
On February 12, 2015, MBBP client Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, filed for a $90 million IPO.
The filing with the SEC arrives one week after insulin pump maker Asante Solutions postponed its proposed $49 million offering.
Valeritas markets a disposable device that delivers basal-bolus insulin therapy for Type 2 diabetes.